Business Update

Sequenom's iPLEX Gold assay favorably received by leading genomic research institutions

Published in Lab Business Week, February 25th, 2007

Sequenom, Inc. (SQNM) announced that its recently launched iPLEX Gold genotyping assay has been favorably received at The Broad Institute, a research collaboration of the Massachusetts Institute of Technology (MIT), Harvard and its affiliated hospitals, and the Whitehead Institute, and at Oxford University Medical Science Division's Wellcome Trust Centre for Human Genetics.

Both centers are among leading research institutions that have adopted the iPLEX Gold assay commercially launched in October 2006.

"We compared data from the new iPLEX Gold assay with the original iPLEX assay, and with iPLEX Gold have achieved a higher level of multiplexing and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-02-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry